Pre-Open Stock Movers 02/22: (CYTX) (TRVN) (BLCM) Higher; (CMRX) (LL) (I) Lower (more...)
Tweet Send to a Friend
Chimerix (NASDAQ: CMRX) 29.2% LOWER; announced detailed results from its Phase 3 SUPPRESS trial of brincidofovir for the prevention of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
